Skip to main content

Find Clinical Trials

Home
Conditions
Transplant Patients With EBV Viremia at High Risk for Developing a Recurrent EBV Lymphoma

Clinical trial condition

Transplant Patients With EBV Viremia at High Risk for Developing a Recurrent EBV Lymphoma

Explore clinical trials studying Transplant Patients With EBV Viremia at High Risk for Developing a Recurrent EBV Lymphoma. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Transplant Patients With EBV Viremia at High Risk for Developing a Recurrent EBV Lymphoma trial results

Completed

Therapeutic Effects of Epstein-Barr Virus Immune T-Lymphocytes Derived From a Normal HLA-Compatible Or Partially-Matched Third-Party Donor in the Treatment of EBV Lymphoproliferative Disorders and EBV-Associated Malignancies

NCT01498484

Conditions: EBV-associated Malignancies, EBV-induced Lymphomas, Transplant Patients With EBV Viremia at High Risk for Developing a Recurrent EBV Lymphoma
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details